Strata Critical Medical Inc Class (SRTA) financials
Strata Critical Medical Inc Class revenue and earnings by year
Strata Critical Medical Inc Class's revenue was $197 million in the fiscal year to December 31, 2025, up 34.3% from the year before. Net income was $41.3 million, 21.0% of revenue. Since the fiscal year to December 31, 2022, revenue has grown 10.5% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 4 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 197 | 147 | 225 | 146 |
| Revenue growth | 34.3% | -34.8% | 54.1% | — |
| Gross profit | 41 | 30 | 42 | 22 |
| Gross margin | 20.9% | 20.2% | 18.7% | 15.2% |
| Operating income | -22 | -23 | -68 | -54 |
| Operating margin | -11.3% | -15.3% | -30.3% | -36.6% |
| Net income | 41 | -27 | -56 | -27 |
| Net margin | 21.0% | -18.6% | -24.9% | -18.7% |
| Diluted EPS | $0.50 | -$0.35 | -$0.76 | -$0.38 |
| Free cash flow | -60 | -36 | -34 | -38 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open SRTA in Markets.
How Strata Critical Medical Inc Class makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Logistics | $48.2M | 66.5% |
| Clinical | $24.3M | 33.5% |
See also: SRTA valuation and P/E history · SRTA returns
No forecast, no recommendation. This page describes Strata Critical Medical Inc Class from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.